# Clinico-immunological Characterization and Immune Tolerance Breakdown in CV2-autoimmunity

> **NCT06620913** · — · ACTIVE_NOT_RECRUITING · sponsor: **Hospices Civils de Lyon** · enrollment: 232 (actual)

## Conditions studied

- CV2 Autoimmunity

## Interventions

- **OTHER:** Description of clinical, immunological and tumor features of patients harboring CV2 Abs

## Key facts

- **NCT ID:** NCT06620913
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-05-01
- **Primary completion:** 2024-09-01
- **Final completion:** 2026-05-01
- **Target enrollment:** 232 (ACTUAL)
- **Last updated:** 2024-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06620913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06620913, "Clinico-immunological Characterization and Immune Tolerance Breakdown in CV2-autoimmunity". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06620913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*